دورية أكاديمية
أعرض في EDS

Partnerships in the introduction of new routine vaccines in Bangladesh: evidence from a prospective process evaluation.

التفاصيل البيبلوغرافية
العنوان: Partnerships in the introduction of new routine vaccines in Bangladesh: evidence from a prospective process evaluation.
المؤلفون: Luies SK; Infectious Diseases Division, icddr,b, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh sharminkhan.luies@gmail.com., Sultana T; Research Program, Bangladesh Institute of Governance and Management, Dhaka, Bangladesh., Budden A; D'EVA Consulting, Washington, District of Columbia, USA., Asaduzzaman M; SanMarkS at iDE (International Development Enterprises), iDE Bangladesh, Dhaka, Bangladesh., Hossain MB; Department of Sociology, Shahjalal University of Science and Technology, Sylhet, Bangladesh., Kelly M; National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia., Gray D; National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia., Uddin MJ; Health Systems and Population Studies Division, icddr,b, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhal, Dhaka 1212, Bangladesh., Sarma H; National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia.
المصدر: BMJ open [BMJ Open] 2022 Sep 26; Vol. 12 (9), pp. e061742. Date of Electronic Publication: 2022 Sep 26.
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
مواضيع طبية MeSH: Immunization Programs*/organization & administration , Pneumococcal Vaccines*/administration & dosage , Poliovirus Vaccine, Inactivated*/administration & dosage, Bangladesh ; Child ; Humans ; Program Evaluation ; Prospective Studies ; Vaccines, Conjugate
مستخلص: Objective: To assess the contribution of partners in the introduction of two new vaccines concurrently: pneumococcal 10-valent conjugate vaccine (PCV-10) and inactivated polio vaccine (IPV) into the routine Expanded Programme on Immunization (EPI) in Bangladesh.
Design: We conducted a prospective process evaluation that included the theory of change development, root cause analysis and in-depth investigation. As part of process tracking, we reviewed relevant documents, observed trainers' and vaccinators' training and key stakeholder meetings. We analysed the data thematically.
Setting: We purposively selected eight Upazila (subdistrict) and one city corporation covering nine districts and seven administrative divisions of Bangladesh.
Participants: Nineteen national key informants were interviewed and 16 frontline health workers were invited to the group discussions considering their involvement in the vaccine introduction process.
Results: The EPI experienced several challenges during the joint introduction of PCV-10 and IPV, such as frequent changes in the vaccine introduction schedule, delays in budget allocation, vaccine supply shortage and higher wastage rates of IPV. EPI addressed these challenges in collaboration with its partners, that is, the World Health Organization (WHO) and United Nations Children's Fund (UNICEF), who provided technical assistance to develop a training curriculum and communication materials and enhanced demand generation at the community level. In addition, the WHO conducted a country readiness assessment for PCV-10, and UNICEF supported vaccine shipment. Other government ministries, City Corporations and municipalities also supported the EPI.
Conclusions: The partnership among the EPI stakeholders effectively addressed various operational challenges during the joint introduction of PCV-10 and IPV helped strengthen Bangladesh's immunisation systems. These accomplishments are attributed to several factors that should be supported and strengthened for future vaccine introductions in Bangladesh and other low and-middle countries.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
References: Lancet. 2007 Feb 3;369(9559):389-96. (PMID: 17276779)
J Health Popul Nutr. 2008 Sep;26(3):295-310. (PMID: 18831226)
Lancet Infect Dis. 2010 Nov;10(11):778-90. (PMID: 20961813)
Lancet. 2009 Sep 12;374(9693):893-902. (PMID: 19748398)
BMC Public Health. 2019 Jul 10;19(1):925. (PMID: 31291922)
J Infect Dis. 2017 Jul 1;216(suppl_1):S52-S56. (PMID: 28838169)
J Infect Dis. 2011 Jul;204 Suppl 1:S82-9. (PMID: 21666218)
J Health Popul Nutr. 2013 Jun;31(2):211-7. (PMID: 23930339)
Vaccine. 2004 Oct 22;22(31-32):4203-14. (PMID: 15474710)
J Infect Dis. 2011 Jul;204 Suppl 1:S90-7. (PMID: 21666219)
Am J Public Health. 2005 May;95(5):800-7. (PMID: 15855455)
Hum Vaccin. 2011 Oct;7(10):1077-82. (PMID: 21941096)
Health Policy Plan. 2012 May;27 Suppl 2:ii5-16. (PMID: 22513732)
BMC Infect Dis. 2010 Sep 03;10:260. (PMID: 20815900)
Bull World Health Organ. 2008 May;86(5):408-16. (PMID: 18545744)
Trop Med Infect Dis. 2018 Jun 25;3(3):. (PMID: 30274468)
BMC Public Health. 2011 Apr 13;11 Suppl 3:S26. (PMID: 21501444)
Health Policy Plan. 2012 May;27 Suppl 2:ii27-38. (PMID: 22513730)
Glob Health Sci Pract. 2014 Dec 10;2(4):381-94. (PMID: 25611473)
فهرسة مساهمة: Keywords: organisation of health services; public health; qualitative research
المشرفين على المادة: 0 (Pneumococcal Vaccines)
0 (Poliovirus Vaccine, Inactivated)
0 (Vaccines, Conjugate)
تواريخ الأحداث: Date Created: 20220927 Date Completed: 20220929 Latest Revision: 20221011
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9516160
DOI: 10.1136/bmjopen-2022-061742
PMID: 36167397
قاعدة البيانات: MEDLINE
الوصف
تدمد:2044-6055
DOI:10.1136/bmjopen-2022-061742